Zalups R K, Barfuss D W, Lash L H
Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, GA 31207, USA.
Chem Biol Interact. 1999 Dec 15;123(3):171-95. doi: 10.1016/s0009-2797(99)00135-0.
Influences of biliary ligation and systemic depletion of glutathione (GSH) or modulation of GSH status on the disposition of a low, non-nephrotoxic i.v. dose of inorganic mercury were evaluated in rats in the present study. Renal and hepatic disposition, and the urinary and fecal excretion, of inorganic mercury were assessed 24 h after the injection of a 0.5-micromol/kg dose of mercuric chloride in control rats and rats pretreated with acivicin (two 10-mg/kg i.p. doses in 2 ml/kg normal saline, 90 min apart, 60 min before mercuric chloride), buthionine sulfoximine (BSO; 2 mmol/kg i.v. in 4 ml/kg normal saline, 2 h before mercuric chloride) or diethylmaleate (DEM; 3.37 mmol/kg i.p. in 2 ml/kg corn oil, 2 h before mercuric chloride) that either underwent or did not undergo acute biliary ligation prior to the injection of mercury. Among the groups that did not undergo biliary ligation, the pretreatments used to alter GSH status systemically had varying effects on the disposition of inorganic mercury in the kidneys, liver, and blood. Biliary ligation caused the net renal accumulation of mercury to decrease under all pretreatment conditions. By contrast, biliary ligation caused significant increases in the hepatic burden of mercury in all pretreatment groups except in theacivicin-pretreated group. Blood levels of mercury also increased as a result of biliary ligation, regardless of the type of pretreatment used. The present findings indicate that biliary ligation combined with methods used to modulate GSH status systemically have additive effects with respect to causing reductions in the net renal accumulation of mercury. Additionally, the findings indicate that at least some fraction of the renal accumulation of inorganic mercury is linked mechanistically to the hepato-biliary system.
在本研究中,我们评估了胆管结扎、谷胱甘肽(GSH)的全身耗竭或GSH状态的调节对低剂量、非肾毒性静脉注射无机汞处置的影响。在对照大鼠以及用阿西维辛(在2ml/kg生理盐水中腹腔注射两次10mg/kg剂量,间隔90分钟,在注射氯化汞前60分钟)、丁硫氨酸亚砜胺(BSO;在4ml/kg生理盐水中静脉注射2mmol/kg,在注射氯化汞前2小时)或马来酸二乙酯(DEM;在2ml/kg玉米油中腹腔注射3.37mmol/kg,在注射氯化汞前2小时)预处理的大鼠中,于注射0.5微摩尔/千克剂量的氯化汞24小时后评估无机汞的肾和肝处置以及尿和粪便排泄,这些大鼠在注射汞之前进行或未进行急性胆管结扎。在未进行胆管结扎的组中,用于全身改变GSH状态的预处理对肾脏、肝脏和血液中无机汞的处置有不同影响。胆管结扎导致在所有预处理条件下汞的净肾蓄积减少。相比之下,胆管结扎导致除阿西维辛预处理组外的所有预处理组中汞的肝脏负担显著增加。无论使用何种预处理类型,胆管结扎都会导致血液中汞水平升高。本研究结果表明,胆管结扎与全身调节GSH状态的方法相结合在降低汞的净肾蓄积方面具有相加作用。此外,研究结果表明,无机汞肾蓄积的至少一部分在机制上与肝胆系统相关。